日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study

3-甲基甲卡西酮 (3-MMC) 剂量递增后的安全性和认知药效学:一项首次人体试验,针对新型合成药物的研究

Ramaekers, Johannes G; Reckweg, Johannes T; Mason, Natasha L; Kuypers, Kim P C; Toennes, Stefan W; Theunissen, Eef L

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study

一项观察性研究表明,死藤水能够增强海马依赖性情景记忆的形成,且不影响经验丰富的死藤水使用者产生虚假记忆的倾向。

Doss, Manoj K; Kloft, Lilian; Mason, Natasha L; Mallaroni, Pablo; Reckweg, Johannes T; van Oorsouw, Kim; Tupper, Nina; Otgaar, Henry; Ramaekers, Johannes G

Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug

低至中等剂量的3-甲基甲卡西酮(3-MMC)可对健康志愿者产生镇痛作用:一项使用新型药物的原理验证研究

Ramaekers, Johannes G; Reckweg, Johannes T; Mason, Natasha L; Kuypers, Kim Pc; Toennes, Stefan W; Theunissen, Eef L

An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans

一项关于人体单次服用帽柱木碱后安全性及神经认知功能的探索性研究

Prevete, Elisabeth; Theunissen, Eef L; Kuypers, Kim P C; Paci, Riccardo; Reckweg, Johannes T; Cavarra, Mauro; Toennes, Stefan W; Ritscher, Sabrina; Bersani, Giuseppe; Corazza, Ornella; Pasquini, Massimo; Ramaekers, Johannes G

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT

评估峰值体验量表作为快速评估5-MeO-DMT精神活性体验强度的工具

Reckweg, Johannes T; Mason, Natasha L; Theunissen, Eef L; Svendsen, Claus B; Terwey, Theis H; Ramaekers, Johannes G

Cortical structural differences following repeated ayahuasca use hold molecular signatures

反复服用死藤水后皮质结构的变化具有分子特征

Mallaroni, Pablo; Mason, Natasha L; Kloft, Lilian; Reckweg, Johannes T; van Oorsouw, Kim; Ramaekers, Johannes G

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis

中等剂量合成大麻素(JWH-018)引起的精神病样症状:对精神病的启示

Theunissen, Eef L; Reckweg, Johannes T; Hutten, Nadia R P W; Kuypers, Kim P C; Toennes, Stefan W; Neukamm, Merja A; Halter, Sebastian; Ramaekers, Johannes G

Spontaneous and deliberate creative cognition during and after psilocybin exposure

在接触裸盖菇素期间和之后,自发性和有意识的创造性认知能力均有所提高。

Mason, N L; Kuypers, K P C; Reckweg, J T; Müller, F; Tse, D H Y; Da Rios, B; Toennes, S W; Stiers, P; Feilding, A; Ramaekers, J G

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers

一项评估吸入式 5-甲氧基-N,N-二甲基色胺制剂 (GH001) 在健康志愿者中安全性和精神活性作用的 1 期剂量范围研究

Reckweg, Johannes; Mason, Natasha L; van Leeuwen, Cees; Toennes, Stefan W; Terwey, Theis H; Ramaekers, Johannes G

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

一项安慰剂对照研究,旨在探讨死藤水、心境和环境对参加死藤水团体静修的参与者心理健康的影响

Uthaug, M V; Mason, N L; Toennes, S W; Reckweg, J T; de Sousa Fernandes Perna, E B; Kuypers, K P C; van Oorsouw, K; Riba, J; Ramaekers, J G